Zacks Investment Research downgraded shares of Abcam PLC (NASDAQ:ABCZY) from a buy rating to a hold rating in a research note released on Monday morning.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Abcam PLC (NASDAQ ABCZY) opened at 14.20 on Monday. Abcam PLC has a 52-week low of $9.13 and a 52-week high of $15.22. The firm has a market cap of $2.89 billion and a price-to-earnings ratio of 51.82. The company’s 50-day moving average price is $14.18 and its 200-day moving average price is $12.75.

COPYRIGHT VIOLATION NOTICE: “Abcam PLC (ABCZY) Downgraded to Hold at Zacks Investment Research” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/03/abcam-plc-abczy-downgraded-to-hold-at-zacks-investment-research.html.

Receive News & Stock Ratings for Abcam PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam PLC and related stocks with our FREE daily email newsletter.